THE ITPA GENOTYPE CORRELATES WITH HEMOLYTIC ANEMIA AND OUTCOME AFTER TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN IN GENOTYPE 1B CHRONIC HEPATITIS C

被引：0
|
作者：
Kurosaki, M. [1 ]
Tanaka, K. [1 ]
Suzuki, Y. [1 ]
Hoshioka, Y. [1 ]
Tamaki, N. [1 ]
Kato, T. [1 ]
Yasui, Y. [1 ]
Hosokawa, T. [1 ]
Ueda, K. [1 ]
Tsuchiya, K. [1 ]
Kuzuya, T. [1 ]
Nakanishi, H. [1 ]
Itakura, J. [1 ]
Takahashi, Y. [1 ]
Asahina, Y. [1 ]
Mizokami, M. [2 ]
Tanaka, Y. [3 ]
Sakamoto, N. [4 ]
Enomoto, N. [5 ]
Izumi, N. [1 ]
机构：
[1] Musashino Red Cross Hosp, Tokyo, Japan
[2] Japan Konodai Hosp, Int Med Ctr, Chiba, Japan
[3] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan
[4] Tokyo Med & Dent Univ, Tokyo, Japan
[5] Univ Yamanashi, Yamanashi, Japan
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60443-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
441
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [41] COMBINATION OF FLUVASTATIN WITH PEGYLATED INTERFERON/RIBAVIRIN THERAPY REDUCES THE VIRAL RELAPSE RATE IN CHRONIC HEPATITIS C INFECTED WITH HCV GENOTYPE 1B
    Atsukawa, M.
    Tsubota, A.
    Kondo, C.
    Itokawa, N.
    Hashimoto, S.
    Fukuda, T.
    Matsushita, Y.
    Kidokoro, H.
    Kobayashi, T.
    Narahara, Y.
    Nakatsuka, K.
    Kanazawa, H.
    Sakamoto, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S428 - S428
  • [42] RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin
    Kokanov, Nikola
    Krajnovic, Milena
    Cupic-Jovanovic, Snezana
    Kozik, Bojana
    Petrovic, Nina
    Bozovic, Ana
    Mandusic, Vesna
    ARCHIVES OF BIOLOGICAL SCIENCES, 2022, 74 (01) : 57 - 66
  • [43] Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
    Legrand-Abravanel, F
    Nicot, F
    Boulestin, A
    Sandres-Sauné, K
    Vinel, JP
    Alric, L
    Izopet, J
    JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (01) : 66 - 69
  • [44] Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
    Fung, James
    Lai, Ching-Lung
    Hung, Ivan
    Young, John
    Cheng, Charles
    Wong, Danny
    Yuen, Man-Fung
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (06): : 808 - 812
  • [45] A UK SINGLE CENTRE EXPERIENCE OF MANAGEMENT OF HEPATITIS C VIRUS GENOTYPE 4 INFECTION WITH PEGYLATED-INTERFERON AND RIBAVIRIN
    Selvapatt, N.
    Habibi, M.
    Brown, A.
    GUT, 2015, 64 : A109 - A109
  • [46] THE EFFECTS OF IL28B AND ITPA GENOTYPES ON ANTIVIRAL RESPONSE AND HEMOLYTIC ANEMIA IN HCV GENOTYPE 1 PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY
    Choi, J.
    Kim, H.
    Park, S.
    Oh, M.
    Jung, E.
    Lee, Y.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S25 - S25
  • [47] A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin
    Selvapatt, Nowlan
    Habibi, Maximillian S.
    Brown, Ashley
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (10) : 1716 - 1721
  • [48] Similar poor results in genotype 4 chronic hepatitis C treatment with interferon and ribavirin compared with genotype 1 treatment
    Mota, AP
    Graus, J
    Blanco, MA
    Pérez-Muñoz, C
    Villlalgordo, C
    Rodero, R
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2003, 95 (03) : 238 - 239
  • [49] Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 275 - 276
  • [50] IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C
    Chayama, Kazuaki
    Hayes, C. Nelson
    Abe, Hiromi
    Miki, Daiki
    Ochi, Hidenori
    Karino, Yoshiyasu
    Toyota, Joji
    Nakamura, Yusuke
    Kamatani, Naoyuki
    Sezaki, Hitomi
    Kobayashi, Mariko
    Akuta, Norio
    Suzuki, Fumitaka
    Kumada, Hiromitsu
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (01): : 84 - 93
12345